Incyte Stock Price (NASDAQ:INCY)

Add to My Stocks
$134.22 $0.43 (0.32%) INCY stock closing price Jul 21, 2017 (Closing)
Prev Close* : $133.79
Market Cap:
Day Low: $133.02
52 Week Low: $75.52
Open: $133.02
Volume: 755991
Day High: $135.43
52 Week High: $153.15

Incyte Stock Articles & Video

more news on INCY stock

Incyte News - From Partners

Better Days Ahead for the Pharma Sector?   by Zacks on Jun 28, 2017

INCY Stockcharts

View INCY PE ratio, PS ratio stocks charts and compare with peers.
INCY Chart
Note: Compare Incyte stock price history with the index and industry peers.

Incyte Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Incyte Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

INCY Industry Peers

Company Price Change (%)
Actelion (ALIOF)278.881.62 (0.58%)
Alexion Pharma (ALXN)131.791.98 (1.53%)
Pfizer (PFE)33.480.06 (0.18%)
Eli Lilly (LLY)84.660.09 (0.11%)
Novartis (NVS)84.990.43 (0.5%)
Geron (GERN)2.80.01 (0.36%)
Merck (MRK)62.630.31 (0.49%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Sarepta Therapeutics (SRPT)43.412.48 (6.06%)
Mirati Therapeutics (MRTX)4.90.25 (5.38%)
Bio-Rad Labs (BIO.B)235.0510.55 (4.7%)
Cytokinetics (CYTK)14.50.65 (4.69%)
Fortress Biotech (FBIO)4.870.2 (4.28%)
Revance (RVNC)23.750.95 (4.17%)
BioDelivery Sciences (BDSI)3.250.1 (3.17%)
Top gainers from Medical-Biomed-Genetics industry
* As of Jul 21, 2017
CompanyPriceChange (%)
Peregrine Pharma (PPHM)4.60.62 (11.88%)
Trevena (TRVN)2.7550.22 (7.41%)
Vital Therapies (VTL)2.650.15 (5.36%)
Achillion Pharma (ACHN)4.110.21 (4.86%)
MannKind (MNKD)1.30.06 (4.41%)
Kindred Biosciences (KIN)7.60.3 (3.8%)
Advaxis (ADXS)6.880.25 (3.51%)
Top losers from Medical-Biomed-Genetics industry
* As of Jul 21, 2017

Incyte Corporation Stock News - Partner Headlines

Incyte Financial Statements

income statement20162015201420132012
Net Sales Or Revenues1.11B753.75M511.49M354.94M297.05M
Net Income104.22M6.53M-48.48M-83.14M-44.32M
Total Operating Expense902.53M676.12M513.29M370.41M295.75M
view Incyte Corporation income statement
balance sheet20162015201420132012
Total Assets1.64B1.01B830.06M629.56M330.41M
Total Liabilities1.22B836.28M911.69M822.67M505.37M
Shareholders Equity419.46M171.15M-81.62M-193.1M-174.95M
view Incyte Corporation balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities24.75M-34.84M-29.11M-4.48M-118.43M
Net Cash From (Used By) Operating Activities304.75M86.53M26.25M9.18M-94.83M
Increase (Decrease) In Prop Plant And Equipment-120.27M-26M-27.87M-4.26M-2.83M
view Incyte Corporation cashflow statement

Incyte Stock Message Board

Incyte stock price ended the last trading day at 133.79. Stock price or share price can be used to find the total market value of a company. Incyte market cap stands at 26.71B as of 20 Jul, 2017. Incyte valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

Demand for a stock decides its stock market price. For example, if more investors want to buy INCY stock than sell it, then Incyte stock price goes up. Conversely, if more investors wanted to sell INCY stock than buy it, there would be greater supply than demand, and the stock price would fall. The volume number in Incyte stock quote data shows the number of shares traded. For Ex: 1130556 Incyte shares were traded as of last trading day, as seen from Incyte stock chart. The board of directors decide what percentage of a company's earnings will be paid out as dividends. Incyte stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.